Primary Immunization of Infants and Children with Group A Streptococcal M Protein

Autor: M. K. Wittner, Albert Dorfman, Eugene N. Fox, Lauren M. Pachman
Rok vydání: 1969
Předmět:
Zdroj: Journal of Infectious Diseases. 120:598-604
ISSN: 1537-6613
0022-1899
DOI: 10.1093/infdis/120.5.598
Popis: It has been well established in experimental animals and concluded from epidemiological studies that immunity to group A streptococcal infection is type-specific [1]. At least 50 serotypes of group A streptococci can be identified by the serological specificity of the M protein. The presence of the M protein on the cell wall protects the microorganism from phagocytosis in the susceptible host. Conversely, antibodies specific for the M protein antigen interact with the streptococcal cell wall, alter the surface properties, and thereby render the bacteria susceptible to phagocytosis. Reviews by Gill [2], Lancefield [1], and Stollerman [3] summarized the studies establishing the type-specificity of group A streptococcal immunity mediated by the bactericidal (opsonic) activity of anti-M antibody. Investigations have shown that M protein vaccines may stimulate a type-specific antibody response. However, occasional local and systemic reactions to these preparations, particularly with repository adjuvants, have demonstrated that partially purified antigens or cell walls are not practical [3]. Fox and Wittner [4] devised procedures for obtaining nontoxic, highly purified M proteins from streptococcal cell walls. With these antigenically homogeneous M proteins, primary typespecific antibodies could be produced in rabbits with relatively small doses of antigen (e.g., 10 [tg) combined with aluminum hydroxide or emulsified with mineral oil. As a result of these trials in
Databáze: OpenAIRE